Results 31 to 40 of about 28,966 (201)

The role of orlistat in management of obesity [PDF]

open access: yes, 2022
Rapidly rising prevalence of obesity is alarming. Obesity predisposes to co-morbidities like hypertension, type 2 diabetes mellitus, dyslipidemias, thus substantially rising healthcare ...
Oetoro, Samuel
core   +2 more sources

Update on Dyslipidemia [PDF]

open access: yesThe Journal of Clinical Endocrinology & Metabolism, 2007
Recently, considerable progress has been made in understanding the genetic basis of dyslipidemias and in studying the safety and efficacy of lipid-lowering drugs for coronary heart disease (CHD) prevention. Novel loci have been identified for monogenic hypercholesterolemia, such as low-density lipoprotein (LDL) receptor (LDLR)-associated protein ...
Abhimanyu Garg, Vinaya Simha
openaire   +3 more sources

The beneficial effects of a water-based aerobic exercise session on the blood lipids of women with dyslipidemia are independent of their training status [PDF]

open access: yes, 2020
OBJECTIVES: To evaluate the acute effects of a session of water-based aerobic exercise on the blood lipid levels of women with dyslipidemia and to compare these results according to their training status.
Alberton, Cristine Lima   +9 more
core   +3 more sources

Approach to Dyslipidemia, Lipodystrophy, and Cardiovascular Risk in Patients with HIV Infection [PDF]

open access: yes, 2010
There is a significant prevalence (20%–80% depending on the population and the study) of lipid disorders and other cardiovascular risk factors in people living with HIV infection.
A Lafeuillade   +25 more
core   +3 more sources

Hyperglycemia and dyslipidemia: Reduced HLA-DR expression in monocyte subpopulations from diabetes patients [PDF]

open access: yes, 2020
Immune dysfunction contributes to the higher risk of communicable and non-communicable diseases among diabetics. HLA-DR expression is a robust marker of immune competence in mononuclear cells, including antigen presentation to CD4 lymphocytes.
Jagannath, Chinnaswamy   +2 more
core   +2 more sources

Statin Therapy in Children [PDF]

open access: yes, 2020
Landmark studies such as the Bogalusa Heart study, Pathobiological Determinants of Atherosclerosis in Youth study, and Muscatine and Young Finns studies established that the atherosclerotic process begins in childhood. Early precursors of atherosclerosis
Ashraf, Ambika Pallikunnath   +1 more
core   +2 more sources

Association of USF1 and APOA5 polymorphisms with familial combined hyperlipidemia in an Italian population. [PDF]

open access: yes, 2015
Familial combined hyperlipidemia (FCH) is a polygenic and multifactorial disease characterized by a variable phenotype showing increased levels of triglycerides and/or cholesterol.
Bloise E   +9 more
core   +1 more source

Secular trends in cholesterol lipoproteins and triglycerides and prevalence of dyslipidemias in an urban Indian population [PDF]

open access: yes, 2008
Background Coronary heart disease is increasing in urban Indian subjects and lipid abnormalities are important risk factors. To determine secular trends in prevalence of various lipid abnormalities we performed studies in an urban Indian population ...
Agrawal, Aachu   +5 more
core   +3 more sources

294 Implementation time of a lipid lowering therapy in patients with dyslipidemia: results of Prysme study [PDF]

open access: yes, 2010
Despite the availability of specific guidelines, the management of dyslipidemia in practice is not optimal.Objective and methodologyPRYSME, a non-interventional multicentre study carried out with 1226 general practitioners, aimed to describe the ...
Bennaceur, Habib   +4 more
core   +1 more source

Resposta nos lípides e nas lipoproteínas séricas ao aconselhamento nutricional exclusivo em indivíduos dislipidêmicos segundo o sexo e a idade [PDF]

open access: yes, 2015
OBJECTIVE: The aim of the present study was to evaluate the plasma lipid responses of dyslipidemic patients to nutritional counseling according to gender and age.
Castanho, Vera Sylvia   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy